Not Medicare Enrolled

Dr. John Wood, MD

Family Medicine · Richardson, TX
Consulting-driven
970 N COIT RD STE 3040, Richardson, TX 75080
9722388092
In practice since 2006 (19 years)
NPI: 1083648257 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wood? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wood

Dr. John Wood is a family medicine specialist in Richardson, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Wood received a total of $13,644 from 32 pharmaceutical and/or device companies across 244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wood is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $13,644 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$13,644
Total received (2018-2024)
Avg $2,274/year across 6 years
Top 3% in TX for family medicine
32
Companies
244
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,051 (51.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,593 (48.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$56
2023
$58
2022
$16
2021
$103
2019
$533
2018
$12,877

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$7,109
AstraZeneca Pharmaceuticals LP
$1,071
Boehringer Ingelheim Pharmaceuticals, Inc.
$481
Amgen Inc.
$470
Novo Nordisk Inc
$451
Merck Sharp & Dohme Corporation
$431
SANOFI-AVENTIS U.S. LLC
$382
Amarin Pharma Inc.
$373
Novartis Pharmaceuticals Corporation
$340
Janssen Pharmaceuticals, Inc
$336
AbbVie, Inc.
$278
Radius Health, Inc.
$250
Gilead Sciences, Inc.
$227
PFIZER INC.
$223
Lilly USA, LLC
$178
Kowa Pharmaceuticals America, Inc.
$157
Shire North American Group Inc
$147
Horizon Pharma plc
$144
Synergy Pharmaceuticals Inc
$131
Takeda Pharmaceuticals U.S.A., Inc.
$128
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$62
Allergan Inc.
$61
Circassia Pharmaceuticals Inc
$44
Sunovion Pharmaceuticals Inc.
$30
Nalpropion Pharmaceuticals, Inc.
$26
Promius Pharma LLC
$21
Astellas Pharma US Inc
$20
Melinta Therapeutics, Inc.
$18
Nalpropion Pharmaceuticals LLC
$17
Lupin Inc.
$14
Sanofi Pasteur Inc.
$14
Aytu BioScience, Inc
$11
Top 3 companies account for 63.5% of total payments
Associated products mentioned in payments ›
ADVAIR · ANORO · Aimovig · Androgel · BEVESPI AEROSPHERE · BREO · BYDUREON · BYSTOLIC · Baxdela · CHANTIX · CONTRAVE · COSENTYX · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · GARDASIL · INVOKANA · JANUVIA · JARDIANCE · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MYDAYIS · MYRBETRIQ · NO_PRODUCT · Natesto · Ozempic · PNEUMOVAX 23 · PRADAXA · PRALUENT · PREVNAR - 13 · Prolia · Repatha · SHINGRIX · SIVEXTRO · SOLIQUA · STEGLATRO · STIOLTO RESPIMAT · SUPRAX · SYMBICORT · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Trulance · Truvada · Tymlos · Utibron · VIBERZI · VYVANSE · Vascepa · Victoza · XARELTO · XIFAXAN · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (52%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for family medicine in TX.

Looking for a family medicine specialist in Richardson?
Compare family medicine physicians in the Richardson area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,548
Per 100K population
59.5
County median income
$74,149
Nearest hospital
MEDICAL CITY PLANO
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wood is a family medicine specialist, with consulting-driven industry engagement in the top 3% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Wood receive payments from pharmaceutical companies?
Yes. Dr. Wood received a total of $13,644 from 32 companies across 244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Wood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →